Physician-Reported Experience and Understanding of Adverse Event Attribution in Cancer Clinical Trials

OBJECTIVES: To report the results of a survey conducted among Mayo Clinic medical oncologists, hematologists, and cancer prevention specialists to better understand the current practice of determining whether an adverse event that a patient experience in a clinical trial is related to the drug under...

Descripción completa

Detalles Bibliográficos
Autores principales: Le-Rademacher, Jennifer G., Storrick, Elizabeth M., Jatoi, Aminah, Mandrekar, Sumithra J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543498/
https://www.ncbi.nlm.nih.gov/pubmed/31193907
http://dx.doi.org/10.1016/j.mayocpiqo.2019.01.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543498/
https://www.ncbi.nlm.nih.gov/pubmed/31193907
http://dx.doi.org/10.1016/j.mayocpiqo.2019.01.002

Ejemplares similares